New drug shows promise for eye nerve inflammation
NCT ID NCT04762017
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 29 times
Summary
This study tested a new drug called OCS-05 in 36 people with acute optic neuritis, a condition that causes sudden vision loss due to nerve inflammation in the eye. The main goal was to see if the drug is safe and tolerable compared to a placebo, while everyone also received standard care. Researchers also measured changes in the eye's nerve layers over six months to explore potential benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU - Nice
Nice, 06000, France
-
CIC Neurosciences - La Pitié Salpêtrière
Paris, 75013, France
-
Foundation Rothschild
Paris, 75019, France
-
Hospices Civils de Lyon
Lyon, 69677, France
Conditions
Explore the condition pages connected to this study.